Skip to main content

Table 5 Relative antibiotics usage regulation issued by Ministry of Health of China

From: Drug-resistance dynamics of Staphylococcus aureus between 2008 and 2014 at a tertiary teaching hospital, Jiangxi Province, China

Time URL; Content; Key points
Jan-28 − 2008 http://www.nhfpc.gov.cn/zhuzhan/wsbmgz/201304/53cdeec6d8f4461583296ab59bf1fb93.shtml. Content: Notice on strengthening the price management of medical institutions to control the unreasonable growth of medical expenses. Key points: Regulate the behavior of medical services, and encourage the use of low-cost drugs.
Apr-15–200 http://www.nhfpc.gov.cn/zhuzhan/wsbmgz/201304/9a70b1ec336846f8b3858262c8ed6e29.shtml. Content: Notice on further strengthening the management of clinical application of antibacterial drugs. Key points: 1. Strengthen the management of perioperative antimicrobial prophylaxis and application; 2. To strengthen the management of clinical application of fluoroquinolones; 3. In strict accordance with the provisions of the management system for the classification of antimicrobial drugs, strengthen the management of clinical application of antibiotics; 4. To strengthen the guidance and supervision of clinical application of antibacterial drugs and strengthen the guidance and supervision of clinical application of antibacterial drugs
Jul-15–2008 http://www.nhfpc.gov.cn/zhuzhan/wsbmgz/201304/caa37dae8bde44bc9a42dd10aeb9ff43.shtml. Content: Notice on strengthening the work of hospital infection control in multi- drug resistant bacteria. Key points: 1. Management of nosocomial infection in multiple drug resistant bacteria; 2. To establish and improve the monitoring of multi-drug resistant bacteria; 3. Prevention and control of the spread of multi-drug resistant bacteria; 4. Strengthen the rational use of antibacterial drugs;5. Strengthen education and training of medical personnel.
Mar-25–2009 http://www.nhfpc.gov.cn/zhuzhan/wsbmgz/201304/0bf024050b7c4f229bc3e49f75f1e0da.shtml. Content: Notice on the relevant issues concerning the clinical application of antimicrobial agents. Key points: 1. In order to strictly control the surgical treatment of type I incision and to strengthen the management of prophylactic application of antibiotics in perioperative period; 2. Strict control of the clinical application of fluoroquinolones; 3. Strict implementation of the management system of antimicrobial drugs; 4. To strengthen the monitoring of clinical microbiology and bacterial resistance, establish the early warning mechanism for the clinical application of antibacterial drugs.
May-7 − 2013 http://www.nhfpc.gov.cn/yzygj/s3585u/201305/823b9d131ff4416ab7b41b2c4e1f0e83.shtml. Content: Notice on further development of the special rectification activities of national antimicrobial drugs. Key words : 1. To clarify the clinical application management responsibility system; 2. Investigation of clinical application of antimicrobial agents; 3. Establishment of a technical support system for clinical application of antibacterial drugs; 4. Strict implementation of the management system of antimicrobial drugs; 5. To establish a system for the selection and evaluation of antimicrobial agents, and to strengthen the management of antimicrobial agents; 6. Increase the clinical application of antimicrobial drugs related indicators control efforts; 7. Surveillance and evaluation of clinical application of antimicrobial agents; 8. Strengthen the detection and monitoring of bacterial resistance in clinical microbiology; 9. Strict management of drug prescribing authority and the qualification management of drug in the drug of the pharmacist; 10. Improve the management and reward system of antibacterial drugs, and seriously investigate and deal with the irrational use of antibacterial drugs; 11. Establish and improve the clinical application of antimicrobial agents and bacterial resistance monitoring network.